title: [Electrophysiologic effects of intravenous cibenzoline succinate, a new class I antiarrhythmic agent].
authors.forename: H
authors.initials: H
authors.lastname: Atarashi
authors.forename: K
authors.initials: K
authors.lastname: Iida
authors.forename: M
authors.initials: M
authors.lastname: Kou
authors.forename: Y
authors.initials: Y
authors.lastname: Hirayama
authors.forename: M
authors.initials: M
authors.lastname: Gotoh
authors.forename: T
authors.initials: T
authors.lastname: Ino
authors.forename: T
authors.initials: T
authors.lastname: Katoh
authors.forename: H
authors.initials: H
authors.lastname: Hayakawa
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000503:physiopathology; D004341:Drug Evaluation; D004594:Electrophysiology; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged
chemical_list: D000889:Anti-Arrhythmia Agents; D007093:Imidazoles; C032151:cifenline